thinXXS Microtechnology

thinXXS Microtechnology

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5.8M

Overview

thinXXS Microtechnology is a specialized contract development and manufacturing organization (CDMO) focused on plastic microfluidic components and systems. Its core value proposition is de-risking and accelerating the product development cycle for diagnostic and life science companies, enabling them to bring complex microfluidic assays to market faster. Backed by the global infrastructure of its parent company, IDEX Health & Science, thinXXS combines deep engineering expertise with scalable manufacturing capabilities, supplying millions of high-precision parts annually to industry leaders.

Medical DevicesDrug Delivery

Technology Platform

Vertically integrated platform for design, micro-injection molding, assembly, and packaging of plastic microfluidic consumables. Includes proprietary technologies like air-free filled blister packs and scalable automation for mass production.

Funding History

2
Total raised:$5.8M
Series A$5M
Grant$800K

Opportunities

Significant growth driven by the expanding market for Point-of-Care diagnostics and complex lab-on-a-chip consumables in IVD and life sciences.
Integration into IDEX's global network provides extensive cross-selling opportunities and access to a broader customer base across North America, Europe, and Asia.

Risk Factors

Revenue concentration risk from a limited number of large diagnostic OEM clients.
Technological disruption from new materials or manufacturing methods could threaten the core plastic injection molding business.
Operational risks include supply chain instability and the challenge of maintaining quality and delivery while scaling complex production.

Competitive Landscape

Competes against other specialized microfluidic CDMOs (e.g., Micronit, Dolomite, microfluidic ChipShop) and large diagnostic companies' in-house manufacturing capabilities. Differentiation is achieved through deep vertical integration, over 20 years of expertise, a focus on high-volume manufacturability, and the global backing of IDEX Health & Science.